Endocrine Society Annual Meeting (ENDO) 2026

Read more

Efficacy and Safety of Resuming Diazoxide Choline Extended-Release (DCCR) after 16-week Randomized Withdrawal in Prader-Willi Syndrome (PWS) (Study C614)

Read more

Mortality Among Patients with Prader-Willi Syndrome (MAP-PWS): An Analysis of Healthcare Utilization in the Year Prior to Death Within a Single U.S. Payer

Read more

Long-Term Reductions of Hyperphagia with Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome

Read more

Impact of Long-Term Diazoxide Choline Extended Release (DCCR) Treatment and the Prader-Willi Syndrome Profile Questionnaire (PWSP)

Read more

Pediatric Endocrine Society (PES), 2026

Read more

Characterizing Outcomes and Differences in Emergency Visits and Hospitalizations in Pediatric Patients With Prader-Willi Syndrome (CODE-PWS)

Read more

Multidisciplinary Team Patterns in Prader-Willi Syndrome (MDT-PWS): Analysis of Medical Geneticists and Specialists Outpatient Visits from a Single U.S. Payer

Read more